Post-HIFU surveillance of localized prostate cancer: role of PSMA-PET imaging versus the standard PSA–mpMRI protocol
Jérémy Mercier, Lucas Bento, Thibaut Cassou-Mounat, Thomas Prudhomme, Séverine Lagarde, Xavier Game, Michel Soulie, Matthieu Thoulouzan, Anne-Sophie Bajeot, Mathieu Roumiguie · 2025
Read Post-HIFU surveillance of localized prostate cancer: role of PSMA-PET imaging versus the standard PSA–mpMRI protocol by Jérémy Mercier, Lucas Bento, Thibaut Cassou-Mounat, Thomas Prudhomme, Séverine Lagarde, Xavier Game, Michel Soulie, Matthieu Thoulouzan, Anne-Sophie Bajeot, Mathieu Roumiguie (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743680.txt.
Description
Jérémy Mercier and co-authors review in 2025 how to watch for prostate cancer return after a focused ultrasound treatment. The treatment, called HIFU, blasts the tumor with sound waves while sparing healthy tissue. Afterward, standard blood tests and scans can miss a return, since treatment changes the gland's shape.
The review gathered eight studies from major databases. Standard MRI scans remain the norm but read the treated zone poorly. A newer scan, PSMA-PET, hunts a marker found on prostate cancer cells. It caught hidden returns with high accuracy, even when blood tests were low and other scans had failed. The authors call it a strong partner to standard checks, pending larger trials.
Catalog record
| CREATOR | Jérémy Mercier, Lucas Bento, Thibaut Cassou-Mounat, Thomas Prudhomme, Séverine Lagarde, Xavier Game, Michel Soulie, Matthieu Thoulouzan, Anne-Sophie Bajeot, Mathieu Roumiguie |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |